Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research

[1]  M. Borrie,et al.  The case-finding study: A novel community-based research recruitment approach for engaging participants with early cognitive decline , 2019, Alzheimer's & dementia.

[2]  G. Jicha,et al.  "From Victimhood to Warriors": Super-researchers' Insights Into Alzheimer's Disease Clinical Trial Participation Motivations. , 2019, The Gerontologist.

[3]  E. Tangalos,et al.  Mild Cognitive Impairment in Geriatrics. , 2018, Clinics in geriatric medicine.

[4]  J. Ankri,et al.  What are the preferences of patients attending a memory clinic for disclosure of Alzheimer's disease? , 2018, Revue neurologique.

[5]  Albert Hofman,et al.  The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study , 2018, The Lancet Neurology.

[6]  D. Cohen,et al.  Publisher's Note , 2017, Neuroscience & Biobehavioral Reviews.

[7]  Howard J. Rosen,et al.  Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups , 2017, Alzheimer disease and associated disorders.

[8]  William T. Hu,et al.  Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience , 2016, Front. Aging Neurosci..

[9]  K. Blennow,et al.  Alzheimer's disease , 2016, The Lancet.

[10]  Gilles O Einstein,et al.  Recruitment of Older Adults: Success May Be in the Details. , 2015, The Gerontologist.

[11]  M. Colin Ard,et al.  Optimal composite scores for longitudinal clinical trials under the linear mixed effects model , 2016 .

[12]  C. Katona,et al.  Attitudes and preferences towards screening for dementia: a systematic review of the literature , 2015, BMC Geriatrics.

[13]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[14]  S. Cutler.  Worries About Getting Alzheimer’s , 2015, American journal of Alzheimer's disease and other dementias.

[15]  H. Buschke,et al.  Findings from the National Memory Screening Day Program , 2015, Journal of the American Geriatrics Society.

[16]  J. Galvin,et al.  Facilitating Alzheimer Disease Research Recruitment , 2014, Alzheimer disease and associated disorders.

[17]  Elizabeth Eckstrom,et al.  Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.

[18]  S. Borson.  Clinical diagnosis and care of dementia: Why it matters (includes introduction to case studies) , 2013, Alzheimer's & Dementia.

[19]  J. Weuve,et al.  Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.

[20]  D. Salmon,et al.  Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics? , 2013, Neuropsychology.

[21]  Frederick A. Schmitt,et al.  Improving dementia care: The role of screening and detection of cognitive impairment , 2013, Alzheimer's & Dementia.

[22]  M. Mintun,et al.  Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology , 2012, The journal of nutrition, health & aging.

[23]  S. McLennan,et al.  Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population , 2011, Journal of geriatric psychiatry and neurology.

[24]  S. Edland,et al.  Power calculations for clinical trials in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[25]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[26]  J. Karlawish,et al.  Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials , 2010, Alzheimer's Research & Therapy.

[27]  F. Schmitt,et al.  Comparison of Recruitment Efforts Targeted at Primary Care Physicians Versus the Community at Large for Participation in Alzheimer Disease Clinical Trials , 2010, Alzheimer disease and associated disorders.

[28]  B. Ghetti,et al.  Novel TARDBP mutation associated with frontotemporal dementia and movement disorder but not motor neuron disease , 2009, Alzheimer's & Dementia.

[29]  Nathaniel Mercaldo,et al.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.

[30]  C. Luis,et al.  Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US , 2009, International journal of geriatric psychiatry.

[31]  J. Morris,et al.  Children of Persons With Alzheimer Disease: What Does the Future Hold? , 2008, Alzheimer disease and associated disorders.

[32]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[33]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[34]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[35]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[36]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[37]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.